All sponsors

Insmed Incorporated $INSM

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING4
READOUTS ≤12 MONTHS1
Open Insmed Incorporated on the live radar map → 📅 $INSM readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Treprostinil Palmitil
NCT05649748
P2/3Active, not recruitingPulmonary Arterial Hypertension912026-12-31
PALM-PAH
NCT07481981
P3RecruitingPulmonary Arterial Hypertension3442028-12-28
PALM-ILD
NCT07179380
P3RecruitingPulmonary Hypertension; Interstitial Lung Disease3442028-12-30
PALM-PPF
NCT07805785
P3RecruitingProgressive Pulmonary Fibrosis; Interstitial Lung Disease8002030-08-31
Treprostinil Palmitil Inhalation Powder
NCT07234032
P3RecruitingPulmonary Hypertension; Interstitial Lung Disease3442031-01-22